ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Biochemical and Biophysical Research Communications
Volume 342, Issue 2, 7 April 2006, Pages 585-588
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (307 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bbrc.2006.02.008    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Inc. All rights reserved.

9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma

Natalia Calonghia, Eleonora Pagnottaa, Carola Parolina, Cristina Tognolia, Carla Bogab and Lanfranco Masottia, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Biochemistry “G. Moruzzi”, Alma Mater Studiorum, University of Bologna, Italy bDepartment of Organic Chemistry “A. Mangini”, Alma Mater Studiorum, University of Bologna, Italy

Received 1 February 2006. 
Available online 10 February 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

The epidermal growth factor has long been known to be strictly correlated with the highly proliferating activities of cancer cells and primary tumors. Moreover, in the nucleus, the epidermal growth factor/epidermal growth factor receptor complex (EGF/EGFR) functions as a transcriptional regulator that activates the cyclin D1 gene. 9-hydroxystearic acid (9-HSA) induces cell proliferation arrest and differentiation in HT29 colon cancer cells by inhibiting histone deacetylase 1 (HDAC1). 9-HSA-treated HT29, when stimulated with EGF, are not responsive and surprisingly undergo a further arrest. In order to understand the mechanisms of this effect, we analyzed the degree of internalization of the EGF/EGFR complex and its interactions with HDAC1. It appears that HDAC1, as modified by 9-HSA, is unable to associate with cyclin D1, interfering with the cell proliferation program, and sequesters the EGF/EGFR complex interrupting the transduction of the mitogenic signal.

Keywords: EGFR; Cyclin D1; HDAC1; 9-HSA; Colon cancer cell; Cell proliferation

Article Outline

Materials and methods
Results
9-HSA diminished signal transduction mediated by EGF/EGFR
9-HSA decreased cyclin D1 expression and modified HDAC1/cyclin D1 complex
9-HSA interfered with EGF signalling
Discussion
Acknowledgements
References




 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.